[A case report of un-resectable pancreas body carcinoma successfully treated by chemoradiotherapy].
We report a case of unresectable pancreatic cancer who survived for 29 months after a successful treatment by concurrent chemo-radiotherapy by gemcitabine and systemic administration of gemcitabine. A 65-year-old woman who was diagnosed as unresectable pancreas body cancer received concurrent chemo (gemcitabine 800 mg/body/w) -radiotherapy (1.8x30 Gy) and systemic chemotherapy (gemcitabine 1,000 mg/body/w) at an outpatient clinic. Twenty nine months after the initial treatment, she was died of peritoneal dissemination. Recently, there are some reports of synergistic effect for combined treatment of gemcitabine and radiation. Clinical course of our case supports the synergistic effect of radiation and gemcitabine.
Nagahama
Takeshi
T
Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital.
Ando
Masayuki
M
Ohara
Toshiya
T
Ganno
Hideaki
H
Hataji
Kenichiro
K
Ami
Katsunori
K
Fukuda
Akira
A
Maruyama
Michio
M
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D010190:Pancreatic Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine